159 filings
4
Singer William S.
10 Apr 24
Synaptogenix / William S. Singer ownership change
4:08pm
4
SNPX
Synaptogenix Inc
10 Apr 24
Synaptogenix / Joshua Silverman ownership change
4:07pm
4
Schechter Jonathan
10 Apr 24
Synaptogenix / JONATHAN SCHECHTER ownership change
4:06pm
4
Bernstein Bruce
10 Apr 24
Synaptogenix / Bruce Bernstein ownership change
4:05pm
8-K
SNPX
Synaptogenix Inc
4 Apr 24
Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing
5:00pm
10-K
2023 FY
SNPX
Synaptogenix Inc
Annual report
1 Apr 24
5:00pm
SC 13G/A
SNPX
Synaptogenix Inc
6 Feb 24
Synaptogenix / INTRACOASTAL CAPITAL ownership change
10:16am
8-K
SNPX
Synaptogenix Inc
21 Dec 23
Departure of Directors or Certain Officers
5:00pm
ARS
2022 FY
SNPX
Synaptogenix Inc
14 Nov 23
Annual report to shareholders
5:05pm
10-Q
2023 Q3
SNPX
Synaptogenix Inc
Quarterly report
14 Nov 23
5:00pm
DEF 14A
SNPX
Synaptogenix Inc
Definitive proxy
13 Nov 23
5:00pm
8-K
SNPX
Synaptogenix Inc
6 Nov 23
Entry into a Material Definitive Agreement
5:00pm
PRE 14A
SNPX
Synaptogenix Inc
Preliminary proxy
3 Nov 23
5:00pm
8-K
SNPX
Synaptogenix Inc
22 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:05pm
10-Q
2023 Q2
SNPX
Synaptogenix Inc
Quarterly report
14 Aug 23
5:00pm
8-K
SNPX
Synaptogenix Inc
19 Jul 23
Study will evaluate drug’s potential neuro-restorative mechanism(s) of action for improving synaptic health and cognitive function in MS patients
8:55am
8-K
SNPX
Synaptogenix Inc
22 Jun 23
Departure of Directors or Certain Officers
5:14pm
10-Q
2023 Q1
SNPX
Synaptogenix Inc
Quarterly report
15 May 23
4:33pm
8-K
SNPX
Synaptogenix Inc
28 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
SNPX
Synaptogenix Inc
14 Apr 23
Submission of Matters to a Vote of Security Holders
5:00pm